Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

NCT00297817 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Disease

Interventions

BIOLOGICAL: serogroup B meningococcal vaccine
BIOLOGICAL: serogroup B meningococcal vaccine
BIOLOGICAL: serogroup B meningococcal vaccine

Sponsor

Novartis Vaccines